Staar Surgical Co Quick Ratio (STAA) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Staar Surgical Co  (NASDAQ: STAA)

Staar Surgical Co's Quick Ratio

STAA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 2.47 above Staar Surgical Co average.

Within Medical Equipment & Supplies industry 71 other companies have achieved higher Quick Ratio than Staar Surgical Co in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 1210, from total ranking in the first quarter 2026 at 1433.

Explain Quick Ratio?
How much Cash & cash equivalents STAA´s has?
What are STAA´s Current Liabilities?




STAA Quick Ratio (Jul 03 2026)
Q2
(Apr 03 2026)
Q1
(Jan 02 2026)
Q4
(Sep 26 2025)
Q3
(Jun 27 2025)
Q2
Y / Y Current Liabilities Change 23.92 % -10.77 % -34 % -7.09 % -10.49 %
Y / Y Cash & cash equivalent Change -4.42 % -26.43 % -18.64 % -18.35 % -19.27 %
Quick Ratio MRQ 2.47 2.69 2.74 3.13 3.21
STAA's Total Ranking # 1210 # 1433 # 1207 # 1213 # 1206
Seq. Current Liabilities Change 20.33 % -10.96 % 11.14 % 4.07 % -13.35 %
Seq. Cash & cash equivalent Change 10.74 % -12.61 % -2.66 % 1.46 % -14.76 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 72
Healthcare Sector # 450
Overall Market # 1255


Quick Ratio Statistics
High Average Low
4.69 2.39 0.5
(Apr 01 2022)   (Apr 01 2016)




Financial Statements
Staar Surgical Co's Current Liabilities $ 73 Millions Visit STAA's Balance sheet
Staar Surgical Co's Cash & cash equivalent $ 181 Millions Visit STAA's Balance sheet
Source of STAA's Sales Visit STAA's Sales by Geography


Cumulative Staar Surgical Co's Quick Ratio

STAA's Quick Ratio for the trailling 12 Months

STAA Quick Ratio

(Jul 03 2026)
12 Months
(Apr 03 2026)
12 Months
(Jan 02 2026)
12 Months
(Sep 26 2025)
12 Months
(Jun 27 2025)
12 Months
Y / Y Current Liabilities TTM Growth -11.15 % -17.82 % -13.8 % 12.6 % 18.78 %
Y / Y Cash & cash equivalent TTM Growth -17.46 % -20.6 % -18.13 % -12.81 % -3.48 %
Quick Ratio TTM 2.74 2.93 3.08 2.85 2.95
Total Ranking TTM # 607 # 663 # 483 # 507 # 504
Seq. Current Liabilities TTM Growth 5.66 % -2.86 % -12.04 % -1.58 % -2.28 %
Seq. Cash & cash equivalent TTM Growth -1.14 % -7.43 % -5.14 % -4.93 % -4.9 %


On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2026 to $73.39 millions, cumulative Quick Ratio decreased to 2.74 above the STAA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 197 other companies have achieved higher Quick Ratio than Staar Surgical Co. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3804.

Explain Quick Ratio?
How much Cash & cash equivalents STAA´s has?
What are STAA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 198
Healthcare Sector # 878
Within the Market # 1210


trailing twelve months Quick Ratio Statistics
High Average Low
4.32 2.23 0.62
(Jul 01 2022)   (Dec 30 2016)




Companies with similar Quick Ratio in the quarter ending Jul 03 2026, within Medical Equipment & Supplies Industry Quick RatioJul 03 2026 MRQ Cash & cash equivalentJul 03 2026 MRQ Current Liabilities
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions

Date modified: 2026-09-08T22:25:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.